World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
53
Citations
19303
World Ranking
4034
National Ranking
1566

Research.com Recognitions

  • 2012 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Edward A. Berger is affiliated with the National Institutes of Health in the United States. Their research primarily spans the fields of immunology and microbiology as well as medicine, with a focus on immunology, oncology, virology, infectious diseases, and genetics.

The research topics covered by Edward A. Berger include:

  • Immune Cell Function and Interaction
  • CAR-T cell therapy research
  • T-cell and B-cell Immunology
  • HIV Research and Treatment
  • Virus-based gene therapy research
  • Viral Infections and Outbreaks Research
  • Viral Infections and Vectors

Notable recent papers authored or co-authored by Edward A. Berger include:

  • CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection, 2022, PLoS Pathogens
  • HIV-1-Specific Chimeric Antigen Receptor T Cells Fail To Recognize and Eliminate the Follicular Dendritic Cell HIV Reservoir In Vitro, 2020, Journal of Virology
  • Evaluation of chimeric antigen receptor T cell therapy in non-human primates infected with SHIV or SIV, 2021, PLoS ONE
  • A Trispecific Anti-HIV Chimeric Antigen Receptor Containing the CCR5 N-Terminal Region, 2020, Frontiers in Cellular and Infection Microbiology
  • HIV-Specific CAR T Cells with CD28 or 4-1BB Signaling Domains Are Phenotypically and Functionally Distinct and Effective at Suppressing HIV and Simian Immunodeficiency Virus, 2022, ImmunoHorizons

Frequent collaborators in Edward A. Berger's research include:

  • Mary S. Pampusch
  • Pamela J. Skinner
  • Emily K. Cartwright
  • Aaron Rendahl
  • Elizabeth Connick

The primary publication venues in which Edward A. Berger has published multiple works are:

  • PLoS ONE
  • Frontiers in Cellular and Infection Microbiology
  • PLoS Pathogens
  • Journal of Virology
  • ImmunoHorizons

Edward A. Berger was recognized as a Fellow of the American Association for the Advancement of Science (AAAS) in 2012.

Best Publications

  • CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1

    Ghalib Alkhatib;Christophe Combadiere;Christopher C. Broder;Yu Feng

  • CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and Disease

    Edward A. Berger;Philip M. Murphy;Joshua M. Farber

  • A new classification for HIV-1

    E. A. Berger;R. W. Doms;E.-M. Fenyö;B. T. M. Korber

  • CD46 is a cellular receptor for human herpesvirus 6.

    Fabio Santoro;Paul E Kennedy;Giuseppe Locatelli;Mauro S Malnati

  • Inherited Resistance to HIV-1 Conferred by an Inactivating Mutation in CC Chemokine Receptor 5: Studies in Populations with Contrasting Clinical Phenotypes, Defined Racial Background, and Quantified Risk

    Peter A. Zimmerman;Alicia Buckler-White;Ghalib Alkhatib;Todd Spalding

  • STRL33, A Novel Chemokine Receptor–like Protein, Functions as a Fusion Cofactor for Both Macrophage-tropic and T Cell Line–tropic HIV-1

    Fang Liao;Ghalib Alkhatib;Keith W.C. Peden;Geetika Sharma

  • Identification of CX3CR1 : a chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1

    Christophe Combadiere;Karl Salzwedel;Erica D. Smith;H. Lee Tiffany

  • Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation.

    O Nussbaum;C C Broder;E A Berger

  • Different Mechanisms of Energy Coupling for the Active Transport of Proline and Glutamine in Escherichia coli

    Edward A. Berger

  • Selective killing of HIV-infected cells by recombinant human CD4- Pseudomonas exotoxin hybrid protein

    Vijay K. Chaudhary;Tamio Mizukami;Thomas R. Fuerst;David J. FitzGerald

  • HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation.

    Ghalib Alkhatib;Massimo Locati;Paul E. Kennedy;Philip M. Murphy

  • Differential Regulation of HIV-1 Fusion Cofactor Expression by CD28 Costimulation of CD4+ T Cells

    Richard G. Carroll;James L. Riley;Bruce L. Levine;Yu Feng

  • Multiple Antiviral Activities of Cyanovirin-N: Blocking of Human Immunodeficiency Virus Type 1 gp120 Interaction with CD4 and Coreceptor and Inhibition of Diverse Enveloped Viruses

    Barna Dey;Danica L. Lerner;Paolo Lusso;Michael R. Boyd

  • Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells.

    P A Ashorn;E A Berger;B Moss

  • Molecular characterization, reactivation, and depletion of latent HIV

    David G Brooks;Dean H Hamer;Philip A Arlen;Lianying Gao

  • Kaposi's sarcoma-associated herpesvirus fusion-entry receptor : cystine transporter xCT

    Johnan A. R. Kaleeba;Edward A. Berger

  • Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis.

    Tamio Mizukami;Thomas R. Fuerst;Edward A. Berger;Bernard Moss

  • Cyanovirin-N Binds to gp120 To Interfere with CD4-Dependent Human Immunodeficiency Virus Type 1 Virion Binding, Fusion, and Infectivity but Does Not Affect the CD4 Binding Site on gp120 or Soluble CD4-Induced Conformational Changes in gp120

    Mark T. Esser;Toshiyuki Mori;Isabelle Mondor;Quentin J. Sattentau

  • A new SIV co-receptor, STRL33.

    Ghalib Alkhatib;Fang Liao;Edward A. Berger;Joshua M. Farber

  • Fusogenic selectivity of the envelope glycoprotein is a major determinant of human immunodeficiency virus type 1 tropism for CD4+ T-cell lines vs. primary macrophages.

    Christopher C. Broder;Edward A. Berger

Frequent Co-Authors

Bernard Moss
Bernard Moss National Institutes of Health
Christopher C. Broder
Christopher C. Broder Uniformed Services University of the Health Sciences
Ira Pastan
Ira Pastan Center for Cancer Research
Paolo Lusso
Paolo Lusso National Institutes of Health
Vijay K. Chaudhary
Vijay K. Chaudhary University of Delhi
Joshua M. Farber
Joshua M. Farber National Institutes of Health
David J. FitzGerald
David J. FitzGerald MRC Laboratory of Molecular Biology
Philip M. Murphy
Philip M. Murphy National Institutes of Health
Dimiter S. Dimitrov
Dimiter S. Dimitrov University of Pittsburgh
Carlos F. Barbas
Carlos F. Barbas Scripps Research Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students pursuing Microbiology in the USA, exploring related online degrees can open various career opportunities in the healthcare and science sectors. One popular option is the fastest online medical billing and coding certificate programs, which offer a quick pathway into medical administrative roles, complementing a scientific background with essential industry skills.

Additionally, those interested in advancing their healthcare expertise might consider online healthcare degrees that pay well. These programs provide flexibility and strong earning potential, making them ideal for professionals aiming to balance education with work.

Public health careers are also a natural extension of microbiology studies. Many students look into which online mph programs are easiest to get into, seeking accessible public health degrees that prepare them for impactful roles in community health and disease prevention.

For those drawn to pediatric health, exploring career options such as becoming a child life specialist can be rewarding. Understanding the child specialist salary and qualification requirements helps students make informed decisions about their professional pathways.

Best Scientists Citing Edward A. Berger

Trending Scientists

Recently Published Articles